US2008175819A1PendingUtilityA1

Vector system

Assignee: OXFORD BIOMEDICA LTDPriority: Jun 4, 1997Filed: Aug 6, 2007Published: Jul 24, 2008
Est. expiryJun 4, 2017(expired)· nominal 20-yr term from priority
C07K 2319/02C12N 15/87C07K 14/485A61K 2039/505A61P 25/00A61P 31/00C07K 2317/622C07K 16/28A61P 27/00C07K 16/30C07K 2319/00C07K 14/70532C12N 2799/027
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a vector system comprising a nucleotide sequence coding for an antibody. In particular, the present invention relates to the use of such a vector system in a subject, where the nucleotide sequence is expressed in vivo to produce said antibody.

Claims

exact text as granted — not AI-modified
1 . A method for delivery of an antibody for treating a non-cancerous disease in a subject, said method comprising directly administering to a cell in the subject a lentiviral vector comprising a nucleotide sequence encoding an antibody, wherein the antibody is expressed in the cell, thereby stimulating an immune response and treating the non-cancerous disease in the subject. 
     
     
         2 . The method of  claim 1 , wherein the non-cancerous disease is an immune system disease, a cardiovascular disease, an infectious disease, an eye disease, or a neurological disorder. 
     
     
         3 . The method of  claim 1 , wherein the antibody is humanized. 
     
     
         4 . The method of  claim 1 , wherein the antibody is a monoclonal antibody. 
     
     
         5 . The method of  claim 1 , wherein the antibody is a single chain antibody. 
     
     
         6 . The method of  claim 1 , wherein the antibody is a human antibody.

Join the waitlist — get patent alerts

Track US2008175819A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.